CSANZ Admin News Archive

Khalia Primer AHA 2022 Travelling Fellow Report

Ms Khalia Primer (SA) at AHA 2022

Khalia Primer is a final year University of Adelaide PhD candidate, based at the South Australian Health and Medical Research Institute.

With the support of the Cardiac Society’s Travelling Fellowship, she attended the 2022 AHA Scientific Sessions conference which was held in Chicago from the 5-7 November.

Khalia presented some key findings from her PhD project in the ATVB Elaine W. Raines Early Career Award session, which also included presenters from Canada, the United States, and the United Kingdom.

“It was such a fantastic experience to present my work in this forum. I received a lot of extremely useful feedback from the ATVB Early Career committee who organised the session, and it was wonderful to meet the other presenters as well.

I presented my work on how diabetes affects endothelial cell metabolism, and on a novel gene therapy our lab has created to augment metabolic reprogramming and improve angiogenesis in ischaemic disease.

I’m extremely grateful to my supervisors, Associate Professor Christina Bursill and Dr Joanne Tan for encouraging me to attend the conference, and for all their support throughout my PhD. Thank you also to the Cardiac Society of Australia and New Zealand for their support in assisting me to attend the AHA conference in November.

I’m definitely hoping to go to Adelaide for the ASM next year! I’m moving to Melbourne for medical school but I always love the CSANZ meetings so I’m really hoping to stay involved.”

See Khalia’s abstract:
“Pyruvate Dehydrogenase Kinase 4 is a Novel Regulator of Endothelial Cell Mitochondrial Respiration in Diabetes-Impaired Angiogenesis: Implications for Preventing Diabetic Vascular Complications” in AHA’s Journal, Circulation

https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.10357

CSANZ Admin News Archive

Dr Adeel Khoja – AHA 2022 Travelling Fellowship Report

Dr Adeel Khoja is a PhD Student (Year-3) at Faculty of Health & Medical Sciences, Adelaide Medical School
The University of Adelaide.

As a final year PhD student, it was an amazing experience to attend and present at the American Heart Association (AHA) Scientific Sessions 2022 held from November 04 to 07, 2022 in Chicago, Illinois, USA and that too after almost 3 years.

My moderated digital poster presentation entitled “Pregnancy Complications Are Associated With Premature Coronary Artery Disease – Linking Three South Australian Cohorts” was held on Monday, November 07, 2022 in the Multi-Generational Cardiovascular Risk: Pregnancy and Childhood session. It was an honour to present at the flagship cardiology conference and to receive meaningful feedback and suggestions from some of the great experts in the field. This unique data linkage project merging three South Australian registries forms a major component of my PhD thesis and it was the first time I presented at an international conference as part of my PhD candidature.

In addition, I also got a chance to meet with Prof Salim Virani who works in the area of cardiovascular research at the Baylor College of Medicine (BCM), Houston, Texas. We had a good discussion regarding premature coronary heart disease registry at BCM, Houston exploring ways to compare it with the South Australian registry and later with the South- East Asian registries (including Pakistan and India). We also had some discussion on post-doctoral opportunities in USA particularly at BCM, Houston which he was aware of and highlighted potential opportunities. I also attended some nice poster sessions on epidemiology and public health, rapid-fire presentations on mHealth and community based interventions on achieving lifestyle goals and evidence-based clinical sessions. Overall, it was an amazing experience to be part of such a prestigious cardiology conference.

View Adeel’s abstract here in AHA’s Journal, Circulation

CSANZ Admin News Archive

Justin Braver – AHA 2022 Travelling Fellowship Report

Mr Justin Braver (VIC) at AHA 2022

Attending the AHA 2022 conference in Chicago was a privilege and I am grateful to the CSANZ for supporting my attendance via a Travelling Fellowship. I am a physiotherapist by background, undertaking a PhD at The University of Melbourne in the Baker Department of Cardiometabolic Health.

My research is exploring the effectiveness of disease management programs that incorporate digital health to prevent recurring cardiovascular events and mortality in patients with an acute coronary syndrome. I concurrently work in industry for a health insurer, whereby I design and implement remotely delivered preventative health programs.

At the AHA, I presented my research in the “Digital Health to Manage Cardiovascular Disease” session. The aim of this study was to assess the effectiveness of a 6-8 week digitally enabled cardiac rehabilitation program on improving risk factors and health status in patients who were hospitalized for coronary artery disease in Australia. Longer term follow-up over 12 months for hospital readmissions and mortality was also evaluated. All participants had private health insurance hospital cover with one provider. We showed that a digitally enabled cardiac rehab program improved clinical, behavioral and lifestyle risk factors. There was also a trend towards lower readmissions and mortality rates in people who undertook either the digitally enabled program or a traditional face-to-face cardiac rehab program compared to a propensity matched control group who did not undertake any cardiac rehabilitation program.

My area of interest at the conference centred around digital health to improve CVD outcomes. Leading researchers from Stanford, Johns Hopkins and the Cleveland Clinic presented on key themes, namely digital health equity (“techequity”), patient centred design, wearables (including their use across the health journey from wellbeing, diagnostics & disease management) and a lot of discussion on the influence of sleep for heart health. Moreover, it was interesting to learn that many of the same challenges that we face here in Australia are also felt globally. The issues around the underutilisation of cardiac rehab and the importance of co-design when developing digitally enabled healthcare programs are key for preventing recurrent events and mortality in patients suffering from acute coronary syndromes.

View Justin’s Abstract, “Effectiveness of a Digital Health Enabled Cardiac Rehabilitation Program in Reducing Recurrent Events For Private Health Insurance Patients in Australia” in AHA Journal, Circulation on the link here and below: https://www.ahajournals.org/doi/abs/10.1161/circ.146.suppl_1.12446?af=R

CSANZ Admin News Archive

New and amended PBS Listings | 1 Dec 2022

Click here for a summary of the new and amended Pharmaceutical Benefits Scheme (PBS) listings that may relate to your practice, including heart failure, hypertension and hypercholesterolaemia.

For further information on broader PBS changes, please visit the PBS website.

Also please note relevant information and authority application forms have been updated and can be accessed through the Services Australia website.

Download FAQs from PBS Online 

CSANZ Admin News Archive

Global shortage of Ozempic (semaglutide) and Trulicity (dulaglutide).

The Therapeutic Goods Administration (TGA) is working with pharmaceuticals and medical organisations to reduce the impact of the global shortage of the two diabetic medicines: Ozempic (semaglutide) and Trulicity (dulaglutide).

NB: There will be no further supplies of Ozempic available in Australia and access to Trulicity is expected to be very limited until the end of March 2023.

Please help disseminate this information out to patients to allow time to access alternative treatments. TGA has published two webpages (links below) providing practical information and advice about these shortages including a link to new clinical guidelines from RACGP:

• Ozempic (semaglutide) shortage web page
• Trulicity (dulaglutide) shortage web page

If you have any questions, please contact the Medicine Shortages Section on +612 6289 4646 [email protected].

CSANZ Admin News Archive

RACP 2023 CPD Framework | Note: Important Changes

Please note the important changes to the CPD activities physicians will need to complete from 1 January 2023, as directed by the Medical Board of Australia and Medical Council of New Zealand (MCNZ) | Te Kaunihera Rata o Aotearoa.

WATCH THE VIDEO (right) as Prof Martin Veysey, Chair of the RACP’s CPD Committee, explains the changes. 

READ MORE about the new requirements on the RACP website and find CPD resources and templates in the MyCPD Interactive Handbook.

JOIN THE WEBINAR: 2023 MyCPD Framework with Q&A on Tuesday 22 November 2022. Discuss the upcoming changes and what they mean for you. Time: 5pm – 6pm AEDT / 7pm – 8pm NZDT. Register now.

If you have any queries or would like to contribute to the developing the College’s resources, then email the relevant location here.  [email protected]  /  [email protected] 

Libby Admin News Archive

New CSANZ and HLC Appointments

Following the recent resignations of Dr Paul Bridgman as Chair of the Education Committee and Prof Stephen Duffy as Honorary Secretary, CSANZ Members are advised the following appointments to these roles.

Prof Jenny Deague (WA) has been appointed by the Board as Chair of the Education Committee and Dr Mayanna Lund (NZ) has been appointed CSANZ Honorary Secretary.

A/Prof Salvatore Pepe has been appointed in-coming Editor-in-Chief of Heart Lung and Circulation. A/Prof Pepe will take over the role at the conclusion of Prof Robert Denniss’ term at the end of 2023.  Prof Denniss will stay on the Board until the November, 2022 Board meeting and a special ceremony will be held at the 2023 AGM to acknowledge Prof Denniss’ service and achievements as HLC Editor-in-Chief.

Posts navigation

1 … 4 5 6 7 8 9 10 11 12 13 14 15